Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Oxycodone/Naloxone in Chinese Patients with Chronic Pain
NCT02880475Phase 1Completed
- Sponsor
- Mundipharma
- Start
- Jun 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of oxycodone in chronic pain (2 arms), sponsored by Mundipharma. Primary endpoints: Area Under the Curve from time 0 to 48 hours, Area Under the Curve from time 0 to last measurable concentration and 6 more. Started Jun 2014; status: completed.
02
Drugs
oxycodone
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT02880475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02880475.